Skip to content
Screener

Pacific Biosciences of California PACB Total Current Liabilities

Total Current Liabilities at other companies

Illumina logo
IlluminaILMN
$1.58B+8.0%
Quanterix Corporation logo
Quanterix CorporationQTRX
$50.37M+4.5%
Revvity logo
RevvityRVTY
$1.28B+90.0%
Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
$119.98M+60.0%
Agilent Technologies logo
Agilent TechnologiesA
$2.27B+12.8%
Rapid Micro Biosystems logo
Rapid Micro BiosystemsRPID
$18.15M+10.7%

Other financials

Income statement

See full
Revenue$39.0M-1.9%
Gross profit$12.6M-13.9%
Operating income-$44.6M+0.5%
Net income-$44.7M-6.7%
EPS (diluted)-$0.140.0%

Balance sheet

See full
Cash & equivalents$62.6M+10.5%
Total debt$61.8M+17.1%
Total equity-$33.2M-154%
Total assets$751.9M-8.9%

Cash flow

See full
Operating cash flow-$35.6M-21.1%
CapEx$1.6M+183%
Free cash flow-$37.1M-24.1%

Valuation

See full
Market cap$357.46M-5.6%
Enterprise value$356.64M-4.8%
P/S2.2×-0.2×

Profitability

See full
Gross margin36.4%+15.0pp
Operating margin-83.5%-37.4pp
Net margin-82.5%-35.5pp
FCF margin-77.5%-13.2pp

Returns & leverage

See full
Return on equity-273.6%+314pp
Debt / equity25.1×+24.5×
Current ratio4.9×-2.0×

Where this comes from

Reported directly by Pacific Biosciences of California in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.

The source filing: Pacific Biosciences of California’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 5:30 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001299130-26-000122
(In thousands, except par value)June 30,2026December 31,2025
Deferred revenue, current16,10315,936
Operating lease liabilities, current1,371448
Other liabilities, current1,7862,031
Total current liabilities68,80672,831
Deferred revenue, non-current3,3393,929
Operating lease liabilities, non-current60,42456,592
Convertible senior notes, net, non-current644,332645,382
Other liabilities, non-current8,162—

Item 1. Financial Statements (unaudited):

FAQ

What is Pacific Biosciences of California's total current liabilities?
Pacific Biosciences of California (PACB) reported total current liabilities of $68.81M in Q2 2026.
How has Pacific Biosciences of California's total current liabilities changed year-over-year?
Pacific Biosciences of California's total current liabilities increased by 15.1% year-over-year, from $59.75M to $68.81M.
What is the long-term trend for Pacific Biosciences of California's total current liabilities?
Over 5 years (2020 to 2025), Pacific Biosciences of California's total current liabilities has grown at a 13.6% compound annual growth rate (CAGR), from $38.5M to $72.83M.
What does total current liabilities mean?
The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.

Ask your AI about Pacific Biosciences of California's total current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude